- Home
- CCIR vs PACB Comparison
CCIR vs PACB Comparison
Compare CCIR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIR
- PACB
- Stock Information
- Founded
- CCIR 2021
- PACB 2000
- Country
- CCIR United States
- PACB United States
- Employees
- CCIR N/A
- PACB N/A
- Industry
- CCIR
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- CCIR
- PACB Industrials
- Exchange
- CCIR NYSE
- PACB Nasdaq
- Market Cap
- CCIR 351.0M
- PACB 364.2M
- IPO Year
- CCIR 2024
- PACB 2010
- Fundamental
- Price
- CCIR $11.17
- PACB $1.13
- Analyst Decision
- CCIR
- PACB Buy
- Analyst Count
- CCIR 0
- PACB 13
- Target Price
- CCIR N/A
- PACB $2.46
- AVG Volume (30 Days)
- CCIR 500.9K
- PACB 8.3M
- Earning Date
- CCIR 01-01-0001
- PACB 05-08-2025
- Dividend Yield
- CCIR N/A
- PACB N/A
- EPS Growth
- CCIR N/A
- PACB N/A
- EPS
- CCIR 0.16
- PACB N/A
- Revenue
- CCIR N/A
- PACB $154,014,000.00
- Revenue This Year
- CCIR N/A
- PACB $7.15
- Revenue Next Year
- CCIR N/A
- PACB $26.20
- P/E Ratio
- CCIR $68.71
- PACB N/A
- Revenue Growth
- CCIR N/A
- PACB N/A
- 52 Week Low
- CCIR $9.92
- PACB $1.08
- 52 Week High
- CCIR $12.80
- PACB $3.70
- Technical
- Relative Strength Index (RSI)
- CCIR N/A
- PACB 35.91
- Support Level
- CCIR N/A
- PACB $1.08
- Resistance Level
- CCIR N/A
- PACB $1.36
- Average True Range (ATR)
- CCIR 0.00
- PACB 0.09
- MACD
- CCIR 0.00
- PACB -0.00
- Stochastic Oscillator
- CCIR 0.00
- PACB 17.24
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.